• 1. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
• 2. An automated computational approach to kinetic model discrimination and parameter estimation?
  Connor J. Taylor,Hikaru Seki,Friederike M. Dannheim,Mark J. Willis,Graeme Clemens,Brian A. Taylor,Thomas W. Chamberlain,Richard A. Bourne React. Chem. Eng., 2021,6, 1404-1411
• 3. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

Introduction to (2-Ethyl-4-Methyl-1,3-Thiazol-5-Yl)Methanol (CAS No. 137267-28-8)

The compound (2-Ethyl-4-Methyl-1,3-Thiazol-5-Yl)Methanol, identified by the CAS number 137267-28-8, is a fascinating organic molecule with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of thiazoles, which are heterocyclic aromatic compounds containing sulfur and nitrogen atoms in their ring structure. The presence of substituents such as ethyl and methyl groups on the thiazole ring adds to its structural complexity and functional versatility.

Recent studies have highlighted the importance of thiazole derivatives in drug discovery and development. The (2-Ethyl-4-Methyl-1,3-Thiazol-5-Yl)Methanol structure has been found to exhibit promising biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties. These findings have sparked interest in exploring its potential applications in the pharmaceutical industry.

The synthesis of (2-Ethyl-4-Methyl-1,3-Thiazol-5-Yl)Methanol involves a multi-step process that typically begins with the preparation of the thiazole ring. Researchers have developed efficient methods to synthesize this compound, often utilizing sulfur-based reagents and appropriate nucleophiles to form the heterocyclic structure. The introduction of ethyl and methyl substituents is achieved through carefully controlled alkylation reactions, ensuring high yields and purity.

One of the most intriguing aspects of this compound is its ability to act as a precursor for more complex molecules. For instance, it can be used as a building block for constructing bioactive agents with enhanced pharmacokinetic properties. Recent advancements in medicinal chemistry have demonstrated that modifying the substituents on the thiazole ring can significantly influence the compound's bioavailability and efficacy.

In terms of physical properties, (2-Ethyl-4-Methyl-1,3-Thiazol-5-Yl)Methanol is known for its stability under various conditions, making it suitable for use in diverse chemical reactions. Its solubility characteristics also play a crucial role in determining its applicability in different industrial processes. Researchers have reported that this compound exhibits good solubility in polar solvents, which is advantageous for its use in pharmaceutical formulations.

The biological evaluation of this compound has revealed its potential as an antioxidant agent. In vitro studies have shown that it effectively scavenges free radicals, which are known to contribute to oxidative stress and cellular damage. This property makes it a promising candidate for applications in skincare products and nutraceuticals aimed at combating aging and environmental stressors.

Furthermore, recent investigations into the anti-inflammatory properties of (2-Ethyl-4-Methyl-1,3-Thiazol-5-Yl)Methanol have provided valuable insights into its mechanism of action. Experimental results indicate that this compound inhibits the production of pro-inflammatory cytokines, suggesting its potential use in treating inflammatory diseases such as arthritis and dermatitis.

The antimicrobial activity of this compound has also been a focal point of recent research efforts. Studies have demonstrated that it exhibits potent activity against a wide range of bacterial and fungal pathogens. This finding underscores its potential as a natural alternative to conventional antibiotics, which are increasingly facing resistance issues.

In conclusion, (2-Ethyl-4-Methyl-1,3-Thiazol-5-Yl)Methanol (CAS No. 137267-28-) is a versatile compound with a wealth of opportunities for further exploration and application across multiple fields. Its unique chemical structure, coupled with its promising biological activities, positions it as a valuable asset in both academic research and industrial development.

• 873-64-3(2-Ethyl-4,5-dimethylthiazole)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)